Mucinous and mucinous cystic tumor of rectum

C3_RECTUM_MUCINO

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 C19|C20
  • Cancer registry: Morphology ICD-O-3 8480
  • Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

161

4. Check minimum number of events

None

161

5. Include endpoints

None

161

6. Filter based on genotype QC (FinnGen only)

159

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 159 50 109
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 68.28 66.86 68.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
161
Matched controls
1610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
187.0
141
*
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
+∞
172.4
133
*
130
Kela drug reimbursment
Malignant tumour
+∞
145.9
117
*
L01BC06
ATC
capecitabine; oral
+∞
114.7
96
*
A03FA01
ATC
metoclopramide; systemic, rectal
26.5
104.0
103
101
WX302
NOMESCO Finland
Thoracal epidural anesthesy
75.4
98.7
55
11
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
1673.2
95.0
83
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
27.5
89.5
72
46
JN4BD
NOMESCO Finland
Extensive body CT
27.3
82.7
65
39
UJF32
NOMESCO Finland
Coloscopy
20.0
74.8
128
261
H02AB02
ATC
dexamethasone; systemic
149.8
63.5
64
7
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
62.7
56
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
55.5
50
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
50.7
46
*
XX3DW
NOMESCO Finland
Time consuming IT work
18.6
48.7
43
31
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
20.1
47.7
40
26
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
47.2
43
*
WZC30
NOMESCO Finland
Teaching
8.8
38.0
63
110
WZC00
NOMESCO Finland
Treatment plan or consultation
7.6
38.0
92
239
Z51.5
ICD-10 Finland
Palliative care
17.0
37.7
34
25
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
35.8
33
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
35.8
33
*
JN4AD
NOMESCO Finland
Body CT examination
11.9
35.5
41
45
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
34.6
32
*
WX408
NOMESCO Finland
General anesthesy, balanced
6.7
32.8
83
220
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
32.4
30
*
JFF23
NOMESCO Finland
Transversostomy
383.3
32.0
31
*
B01AB05
ATC
enoxaparin; parenteral
6.3
30.6
99
324
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
30.1
28
*
8480/3-C19.9
ICD-O-3
Mucinous adenocarcinoma of rectosigmoid junction
+∞
30.1
28
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
29.0
27
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
29.0
27
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
336.7
28.7
28
*
D75
ICPC
Malignant neoplasm colon/rectum
336.7
28.7
28
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.4
28.3
51
95
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
27.9
26
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
27.9
26
*
JG1BG
NOMESCO Finland
MRI of rectum
+∞
26.8
25
*
TJF80
NOMESCO Finland
Ostomy education
161.0
26.5
27
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
42.2
25.4
31
9
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
24.6
23
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
23.5
22
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
73.4
22.6
25
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
22.4
21
*
N02AA05
ATC
oxycodone; systemic
5.4
21.4
55
141
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
21.3
20
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.1
21.3
26
30
ZXE20
NOMESCO Finland
More than three and less than five hours
5.6
20.8
49
116
B01AB10
ATC
tinzaparin; parenteral
6.9
20.0
35
62
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.2
19.5
39
79
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
19.1
18
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
20.9
19.1
28
16
JFB00
NOMESCO Finland
Partial resection of small intestine
213.9
19.0
19
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
17.4
18.5
29
20
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
18.1
17
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.8
17.9
38
81
JN4CD
NOMESCO Finland
Very extensive body CT
29.5
17.5
23
9
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
17.0
16
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
17.0
16
*
Z93.3
ICD-10 Finland
Colostomy status
188.7
16.8
17
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
15.9
15
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
176.4
15.8
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
176.4
15.8
16
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
176.4
15.8
16
*
SPAT1262
SPAT
Handing over of treatment supplies
4.0
14.9
56
188
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
+∞
14.8
14
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
164.3
14.7
15
*
SPAT1125
SPAT
Stoma care and guidance
21.7
14.7
21
11
WX402
NOMESCO Finland
General anaesthesia
4.3
14.5
46
136
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
13.7
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
13.7
13
*
A04AA01
ATC
ondansetron; systemic, rectal
18.8
13.4
20
12
ZXC96
NOMESCO Finland
Robot assisted procedure
54.8
13.1
15
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
22.3
12.8
18
9
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
12.7
12
*
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
+∞
12.7
12
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
12.7
12
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
12.7
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
12.7
12
*
ZX120
NOMESCO Finland
Intravenous
5.5
11.9
25
52
JFF10
NOMESCO Finland
Loop enterostomy
+∞
11.6
11
*
WF002
NOMESCO Finland
Radical radiotherapy
128.8
11.6
12
*
UJG02
NOMESCO Finland
Proctoscopy
17.1
11.1
17
11
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.4
11.1
31
82
WW500
NOMESCO Finland
Blood transfusion
17.6
10.6
16
10
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
10.5
10
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
10.5
10
*
Z93
ICD-10 Finland
Artificial opening status
+∞
10.5
10
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
10.5
10
*
JAH00
NOMESCO Finland
Laparotomy
12.5
10.4
18
16
K56.7
ICD-10 Finland
Ileus, unspecified
18.2
10.1
15
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.6
9.9
16
12
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.6
9.9
16
12
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
58.6
9.8
11
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.6
9.6
19
22
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.5
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.5
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.5
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.5
9
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
5.3
9.3
20
42
JHA00
NOMESCO Finland
Anal or perianal incision
52.9
8.8
10
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.6
8.8
22
53
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.2
8.4
24
64
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
8.4
8
*
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
8.4
8
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
+∞
8.4
8
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
8.4
8
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
8.4
8
*
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
+∞
8.4
8
*
JGB37
NOMESCO Finland
Laparoscopic wide excision of rectum
+∞
8.4
8
*
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
26.5
7.7
10
*
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
83.8
7.5
8
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.9
7.4
17
38
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
16.7
7.3
11
7
D18
ICPC
Change in faeces/bowel movements
10.0
6.9
13
14
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.4
6.8
14
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
6.8
30
108
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
9.3
6.7
13
15
WX704
NOMESCO Finland
Intubation
4.1
6.6
19
51
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
7.1
6.5
15
23
ZZR00
NOMESCO Finland
Flap of skin
72.6
6.5
7
*
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
72.6
6.5
7
*
L03AA13
ATC
pegfilgrastim; parenteral
72.6
6.5
7
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
9.9
6.4
12
13
R4190
NOMESCO Finland
Nutritional therapy
11.7
6.4
11
10
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
18.9
6.3
9
5
WX600
NOMESCO Finland
Single shot through catheter
27.9
6.3
8
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
L01XE21
ATC
[U] regorafenib
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
369
Kela drug reimbursment
Regorafenib
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.9
6.2
19
53
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
6.2
45
211
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.6
6.1
11
11
JAH01
NOMESCO Finland
Laparoscopy
7.8
6.1
13
18

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
133
70
104.50
191.71
11.7
1.3
15.67
2.59
ug/l
2.31
124
54
45
26
23.63
57.11
6.2
1.5
43.18
14.72
u/ml
0.80
38
18
70
114
10.09
45.63
1.6
1.3
—
—
—
0
0
39
34
14.82
39.34
1.6
1.2
—
—
—
0
0
115
516
5.30
22.21
4.0
2.3
—
—
—
0
0
83
344
3.92
16.50
5.7
3.6
—
—
—
0
0
119
639
4.31
15.93
16.5
15.9
1.25
1.40
inr
1.04
38
166
44
119
4.71
15.62
3.5
1.8
8.86
8.08
umol/l
0.10
35
104
81
348
3.67
14.93
2.5
1.5
—
—
—
0
0
81
355
3.58
14.35
3.4
2.0
—
—
—
0
0
51
165
4.06
14.19
11.4
6.4
104.45
104.16
mmol/l
0.16
51
165
116
658
3.73
13.27
22.4
5.9
3.87
4.41
e9/l
1.51
103
573
31
78
4.68
11.85
1.2
1.0
—
—
—
0
0
48
182
3.33
10.21
3.5
2.7
0.78
0.83
mmol/l
1.73
48
169
73
354
2.94
10.12
3.8
3.1
—
—
—
0
0
101
600
2.83
9.29
7.8
6.0
1.18
1.21
mmol/l
2.29
81
514
41
153
3.25
8.84
10.5
7.6
1.40
1.32
mmol/l
0.04
34
127
24
64
4.23
8.43
12.3
10.8
—
—
—
0
0
59
289
2.64
7.64
1.3
1.3
—
—
—
0
0
39
160
2.90
7.04
3.3
4.8
1.01
1.02
mmol/l
0.10
39
146
88
545
2.36
6.62
7.5
5.5
1.18
1.21
mmol/l
1.75
78
482
27
93
3.29
6.53
8.4
4.8
—
—
—
0
0
40
186
2.53
5.58
3.0
1.7
—
—
—
0
0
53
284
2.29
5.38
5.5
3.2
78.38
83.88
%
0.66
53
277
109
780
2.23
5.32
6.3
3.9
794.40
3384.08
e6/l
—
5
12
17
52
3.54
4.90
2.1
1.8
1.03
1.35
ug/l
0.20
17
44
111
846
2.00
4.01
7.1
4.0
—
—
—
0
0
81
559
1.90
3.91
5.8
5.1
20.91
26.17
%
3.87
74
515
80
558
1.86
3.67
5.9
4.9
63.47
58.27
%
2.83
73
516
24
107
2.46
3.60
8.3
8.2
—
—
—
0
0
44
254
2.01
3.54
3.0
2.1
11.62
3.75
e6/l
0.67
39
224
59
378
1.89
3.50
3.4
2.7
15.64
235.17
e6/l
0.69
48
288
76
534
1.80
3.31
5.4
4.9
0.48
0.65
%
1.95
68
486
77
548
1.78
3.18
5.6
4.9
2.31
3.07
%
2.53
70
503
53
338
1.85
3.14
3.8
3.4
7.39
7.40
ph
0.20
12
54
83
607
1.76
3.09
5.2
4.9
1.41
1.82
e9/l
4.80
73
528
80
579
1.76
3.09
5.1
3.6
0.00
0.01
estimate
0.50
17
105
77
552
1.76
3.07
6.0
5.2
9.10
8.88
%
0.18
70
506
7
12
6.04
3.05
1.6
1.4
85.77
62.58
pmol/l
—
7
12
80
581
1.75
3.04
6.8
5.1
0.00
0.00
estimate
-0.00
16
98
43
259
1.90
3.02
18.8
4.5
—
—
—
0
0
29
154
2.08
2.89
1.7
1.7
—
—
—
0
0
17
73
2.49
2.76
2.3
2.3
—
—
—
0
0
79
590
1.67
2.59
5.2
3.6
0.00
0.00
estimate
-0.00
14
93
82
619
1.66
2.57
5.5
4.9
0.13
0.21
e9/l
5.81
71
532
43
272
1.79
2.56
3.8
4.0
2489.88
218.85
ng/l
0.56
32
232
110
1267
0.58
2.45
4.7
4.9
1.33
1.42
mmol/l
1.76
103
1139
19
92
2.21
2.38
2.7
2.9
1.23
1.22
mmol/l
0.13
14
79
9
28
3.34
2.34
2.2
2.0
109.00
126.43
g/l
—
9
18
61
435
1.65
2.34
3.8
3.2
44.06
80.26
e6/l
0.61
50
306
79
602
1.61
2.32
5.1
4.9
0.03
0.04
e9/l
1.67
66
513
115
1305
0.58
2.32
5.0
5.5
2.66
2.60
mmol/l
0.26
102
1174
72
537
1.62
2.30
17.4
8.3
0.00
0.00
e9/l
0.69
61
435
40
256
1.75
2.28
3.4
2.8
505.81
549.68
mosm/kgh2o
0.66
31
213
29
168
1.89
2.27
1.7
2.3
17.09
23.82
%
1.81
24
152
78
597
1.59
2.22
4.9
4.9
0.66
0.62
e9/l
0.31
67
507
47
317
1.68
2.22
5.7
3.6
—
—
—
0
0
112
1275
0.60
2.19
4.7
4.9
4.50
4.46
mmol/l
0.14
104
1152
48
327
1.67
2.18
3.1
2.5
—
—
—
0
0
8
26
3.18
2.04
3.9
2.4
—
—
—
0
0
108
1234
0.62
2.04
4.6
4.4
1.37
1.30
mmol/l
0.44
102
1100
72
556
1.53
1.89
5.4
5.3
—
—
—
0
0
13
60
2.27
1.83
1.2
1.3
—
—
—
0
0
34
221
1.68
1.82
2.0
1.7
31.94
29.67
s
0.73
34
211
5
13
3.93
1.73
1.4
1.4
4.00
287.27
u/ml
—
5
13
14
70
2.10
1.65
3.5
2.2
—
—
—
0
0
136
1229
1.69
1.60
37.2
13.1
42.71
24.08
mg/l
6.16
130
939
48
352
1.52
1.56
3.2
2.6
0.53
0.39
e6/l
0.21
37
259
9
37
2.52
1.50
4.0
2.4
22.98
24.96
mmol/l
—
9
37
17
95
1.88
1.50
4.4
3.3
—
—
—
0
0
6
22
2.79
1.45
2.0
2.1
—
—
—
0
0
43
315
1.50
1.39
6.2
3.7
0.00
0.00
estimate
-0.00
13
92
23
145
1.68
1.38
2.4
3.4
1.63
1.99
mmol/l
0.22
18
116
56
434
1.45
1.37
3.9
4.3
—
—
—
0
0
13
69
1.96
1.33
3.8
2.9
1.33
0.32
e6/l
0.76
13
69
13
74
1.82
1.10
3.6
4.3
1.00
0.27
%
—
5
22
7
33
2.17
1.07
5.6
3.8
—
—
—
0
0
13
76
1.77
1.02
6.7
4.2
0.20
0.06
%
—
5
18
7
35
2.04
1.01
1.7
1.8
—
—
—
0
0
19
125
1.59
0.99
2.0
3.2
—
—
—
0
0
12
73
1.70
0.84
5.4
4.6
—
—
—
0
0
26
344
0.71
0.83
1.7
1.7
1.52
1.32
mmol/l
0.62
21
273
106
1153
0.76
0.83
4.4
4.4
2.13
2.03
mu/l
0.51
96
1006
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
119
1272
0.75
0.79
4.5
5.0
6.17
6.14
mmol/l
0.08
113
1128
80
898
0.78
0.79
3.4
3.6
14.89
15.13
pmol/l
0.37
69
780
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
11
168
0.63
0.72
1.3
1.2
—
—
—
0
0
5
26
1.95
0.71
1.6
1.7
—
—
—
0
0
10
61
1.68
0.70
9.8
3.8
—
—
—
0
0
66
576
1.25
0.66
3.8
4.0
23.64
103.79
ng/l
0.83
47
438
13
87
1.54
0.65
6.5
4.0
1.90
0.95
%
—
5
28
5
29
1.75
0.64
1.0
1.2
—
—
—
0
0
8
50
1.63
0.62
3.6
5.2
—
—
—
0
0
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
99
920
1.20
0.49
4.7
4.1
—
—
—
0
0
28
230
1.26
0.46
1.1
1.3
1.70
1.47
u/ml
—
7
65
6
94
0.62
0.43
1.0
1.4
—
—
—
0
0
24
196
1.26
0.42
3.1
2.7
0.36
2.51
e6/l
2.20
14
103
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
314.38
—
0
16
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
7
105
0.65
0.40
1.1
1.9
64.49
67.02
g/l
—
7
92
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
98
919
1.17
0.40
3.6
4.1
18.13
11.92
mm/h
1.90
93
815
13
99
1.34
0.37
1.0
1.3
—
—
—
0
0
138
1337
1.23
0.35
46.7
15.5
80.14
84.07
umol/l
0.96
138
1337
6
44
1.38
0.35
1.0
1.1
—
—
—
0
0
7
97
0.71
0.32
1.0
1.4
—
—
—
0
0
7
55
1.28
0.30
1.0
1.2
—
—
—
0
0
62
572
1.14
0.30
2.1
2.0
81.03
95.10
pmol/l
1.43
44
285
37
412
0.87
0.28
3.9
3.4
—
—
—
0
0
9
72
1.26
0.26
2.1
2.6
0.70
0.62
%
—
9
72
9
72
1.26
0.26
1.2
1.2
—
—
—
0
0
9
75
1.21
0.25
2.1
2.7
0.86
1.21
%
—
9
75
46
500
0.89
0.24
3.5
3.9
5.30
8.41
mg/mmol
0.59
30
306
29
258
1.15
0.23
7.7
3.8
1.01
1.02
kg/l
—
6
35
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
138.87
—
0
10
18
155
1.18
0.21
2.9
1.4
—
—
—
0
0
43
465
0.90
0.20
2.7
3.2
7.36
7.72
mmol/l
0.27
37
367
23
203
1.16
0.20
1.1
1.3
2.44
3.00
g/l
1.00
16
111
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
43
464
0.90
0.20
2.8
3.3
49.62
205.10
mg/l
0.58
31
297
14
118
1.20
0.20
1.2
1.4
—
—
—
0
0
8
69
1.17
0.17
5.1
4.1
—
—
—
0
0
6
75
0.79
0.16
1.0
1.4
—
47.22
—
0
9
132
1295
1.11
0.15
38.0
12.6
—
—
—
0
0
12
137
0.87
0.12
1.3
1.5
—
—
—
0
0
10
116
0.85
0.12
3.9
2.7
—
—
—
0
0
11
95
1.17
0.12
1.0
1.4
—
—
—
0
0
71
685
1.07
0.12
3.7
3.9
2.49
2.05
ug/l
0.57
58
600
140
1381
1.11
0.11
58.5
19.2
37.27
40.64
%
6.07
130
1270
18
198
0.90
0.11
1.2
1.3
13.77
42.68
iu/ml
—
6
67
5
43
1.17
0.10
3.0
1.7
—
—
—
0
0
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
29
272
1.08
0.10
1.8
1.7
994.73
1162.86
nmol/l
0.56
24
199
29
272
1.08
0.10
4.6
3.4
—
—
—
0
0
5
61
0.81
0.08
5.4
3.1
4.63
4.36
pmol/l
—
5
54
12
110
1.10
0.05
1.4
1.4
—
—
—
0
0
36
372
0.96
0.04
2.5
2.8
0.73
0.71
ug/l
0.04
24
254
18
177
1.02
0.00
1.3
1.3
0.96
13.13
u/ml
—
9
64
6
64
0.94
0.00
3.7
2.0
493.83
366.46
ug/l
—
6
59
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
9
94
0.95
-0.00
1.0
1.2
—
—
—
0
0
5
57
0.87
-0.00
1.0
1.3
79.20
169.23
u/ml
—
5
50
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.87
-0.00
5.4
5.1
24.84
25.72
mmol/l
—
5
52
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
8.30
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
13.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
997.71
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
10.79
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_RECTUM_MUCINO – Mucinous and mucinous cystic tumor of rectum

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).